101 related articles for article (PubMed ID: 9583965)
1. Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1995 Sep; 87(9):687-92. PubMed ID: 9583965
[TBL] [Abstract][Full Text] [Related]
2. Modified recalcification time: a global coagulation screening test.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1993 Aug; 85(8):611-6. PubMed ID: 8371283
[TBL] [Abstract][Full Text] [Related]
3. Are hypertensives hypercoagulable?
Miller MA; Spillert CR; Ponnudurai R; Bonthu S; Lazaro EJ
J Natl Med Assoc; 1995 Jan; 87(1):71-2. PubMed ID: 7869410
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability in arterial disease.
Spillert CR; Milazzo VJ; Suval WD; Lazaro EJ
Angiology; 1989 Oct; 40(10):886-9. PubMed ID: 2802258
[TBL] [Abstract][Full Text] [Related]
5. Deceptive prothrombin and activated partial thromboplastin times in alcoholic cirrhosis.
Sirikonda PR; Spillert CR; Koneru B; Ponnudurai R; Wilson DJ; Lazaro EJ
J Natl Med Assoc; 1996 May; 88(5):306-9. PubMed ID: 8667440
[TBL] [Abstract][Full Text] [Related]
6. Prothrombotic effects of endothelin-2 (ET-2).
Raff GW; Spillert CR; Wilson DJ; Lazaro EJ
Agents Actions; 1993; 39 Spec No():C104-5. PubMed ID: 8273542
[TBL] [Abstract][Full Text] [Related]
7. Effect of methylprednisolone on coagulation.
Pandit HB; Spillert CR
J Natl Med Assoc; 1999 Aug; 91(8):453-6. PubMed ID: 12656434
[TBL] [Abstract][Full Text] [Related]
8. Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.
Spillert CR; Sun S; Miller MA; Lazaro EJ
J Natl Med Assoc; 1994 Sep; 86(9):686-8. PubMed ID: 7966432
[TBL] [Abstract][Full Text] [Related]
9. Prediction of clinical course in diabetes using a simple coagulation test.
Spillert CR; Milazzo VJ; Pastena JA; Lazaro EJ
J Natl Med Assoc; 1989 Jan; 81(1):81-3. PubMed ID: 2724359
[TBL] [Abstract][Full Text] [Related]
10. Shortened endotoxin-activated clotting times in patients with carcinoma.
Spillert CR; Lazaro EJ
Am Surg; 1987 Mar; 53(3):164-6. PubMed ID: 3548512
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-induced necrosis: a monocyte-mediated hypercoagulable effect.
Spillert CR; Sun S; Ponnudurai R; Miller MA; Lazaro EJ
J Natl Med Assoc; 1995 Jul; 87(7):508-9. PubMed ID: 7636898
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the monocyte to thrombotic potential.
Spillert CR; Lazaro EJ
Agents Actions; 1991 Sep; 34(1-2):28-9. PubMed ID: 1793044
[TBL] [Abstract][Full Text] [Related]
14. Recalcification time in breast disease.
Sofia CA; Spillert CR; Pastena JA; Lazaro EJ
J Natl Med Assoc; 1988 Nov; 80(11):1214-6. PubMed ID: 3249326
[TBL] [Abstract][Full Text] [Related]
15. [Cancer, hypercoagulability and thrombosis].
Sánchez Avalos JC
Sangre (Barc); 1971; 16(2):151-8. PubMed ID: 5314487
[No Abstract] [Full Text] [Related]
16. [Thrombinography: towards a globalization of coagulation tests].
Péters P; Gothot A
Rev Med Liege; 2009 Apr; 64(4):199-203. PubMed ID: 19514539
[TBL] [Abstract][Full Text] [Related]
17. The serial thromboplastin dilution test: a presumptive test for hypercoagulability.
Wolf P; Williams S
Thromb Res; 1976 Aug; 9(2):209-14. PubMed ID: 788224
[No Abstract] [Full Text] [Related]
18. [Clinical value of a new method of therapeutic control of heparin].
Pizzuto J; Garcia S; de la Paz Reyna M; Morales MR; Avilés A; Zavala B; Ponce L; Gaos C
Arch Inst Cardiol Mex; 1978; 48(2):373-86. PubMed ID: 666447
[TBL] [Abstract][Full Text] [Related]
19. [The kaolin-activated recalcification test in the screening of coagulation disorders and in the control of anticoagulant therapy].
Barberi G; Fiocca S
Quad Sclavo Diagn; 1977 Jun; 13(2):167-75. PubMed ID: 594303
[TBL] [Abstract][Full Text] [Related]
20. Comparison of haemostatic parameters in arterial and venous blood from patients with peripheral arterial occlusive disease.
Woller T; Lawall H; Amann B; Angelkort B
Vasa; 1999 Feb; 28(1):10-4. PubMed ID: 10191700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
